Oppenheimer analyst Brian Bittner lowered the firm’s price target on Pinstripes (PNST) to $2 from $5 and keeps an Outperform rating on the ...

Oppenheimer moved Target (TGT) back to “top pick status” while keeping an Outperform rating on the shares with a $165 price target The firm ...

Money makes money - and these six South Africans have made a lot of it over the years. And by a lot, we mean a LOT!

On Friday, Kyndryl Holdings Inc (KD) stock saw a modest uptick, ending the day at $33.05 which represents a slight increase of $0.56 or 1.72% from the prior close of $32.49. The stock opened at $32.83 ...

Wicked” and “Gladiator II” breathed fresh life into the box office with a combined $270 million in ticket sales.

A movie producer’s equestrian estate just hit the market in Malibu. Listed for $17.3 million, the four-acre property off ...

On Friday, Syros Pharmaceuticals Inc (SYRS) stock saw a modest uptick, ending the day at $0.29 which represents a slight increase of $0.03 or 11.54% from the prior close of $0.26. The stock opened at ...

First there was “Barbenheimer.” Now there’s “Glicked.” In a change from Take 2 Blog’s usual format, Rebecca and Joe will each review a different movie this week to celebrate “Glicked.” Similar to ...

With a combined $270 million in worldwide ticket sales, “Wicked” and “Gladiator II” breathed fresh life into a box office ...

Christopher Nolan is already working on his next epic, following the success of his 2023 movie Oppenheimer, which brought the story of the real life physicist J. Robert Oppenheimer to the masses.

Whales with a lot of money to spend have taken a noticeably bullish stance on Soleno Therapeutics. Looking at options history ...